Clovis Oncology, Inc. filed a third amended joint plan of liquidation in the US Bankruptcy Court on June 3, 2023. As per the third amended joint plan of liquidation filed, prepetition financing claims shall be allowed in the amount of $346.99 million. There are no changes in the treatment of any claim class or sources of plan funding.

Debtor filed a revised third amended joint plan of liquidation in the US Bankruptcy Court on June 13, 2023. As per the amended plan filed, there are no changes in the treatment of any claim class or sources of plan funding.